Evogene Ltd. (EVGN)

NASDAQ: EVGN · IEX Real-Time Price · USD
-0.004 (-0.53%)
Nov 30, 2023, 10:39 AM EST - Market open

Evogene Revenue

Evogene had revenue of $5.72M in the twelve months ending September 30, 2023, with 331.52% growth year-over-year. Revenue in the quarter ending September 30, 2023 was $3.77M with 708.37% year-over-year growth. In the year 2022, Evogene had annual revenue of $1.68M with 80.11% growth.

Revenue (ttm)
Revenue Growth
P/S Ratio
Revenue / Employee
Market Cap
32.61M USD

Revenue Chart


Fiscal Year End Revenue Change Growth
Dec 31, 20221.68M745.00K
Dec 31, 2021930.00K-110.00K
Dec 31, 20201.04M287.00K
Dec 31, 2019753.00K-994.00K
Dec 31, 20181.75M-1.63M
Dec 31, 20173.38M-3.16M
Dec 31, 20166.54M-4.59M
Dec 31, 201511.13M-3.38M
Dec 31, 201414.51M-3.07M
Dec 31, 201317.58M509.00K
Dec 31, 201217.07M2.17M
Dec 31, 201114.90M2.34M
Dec 31, 201012.56M--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Centogene 55.72M
electroCore 13.40M
Bolt Biotherapeutics 7.20M
BeyondSpring 1.35M
Gain Therapeutics 55.18K
Revenue Rankings